{"id":26789,"date":"2021-06-29T12:12:20","date_gmt":"2021-06-29T12:12:20","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/pl\/portfolio\/olazax-disperzi"},"modified":"2023-03-07T19:51:10","modified_gmt":"2023-03-07T19:51:10","slug":"olazax-disperzi","status":"publish","type":"portfolio-products","link":"https:\/\/www.neuraxpharm.com\/pl\/portfolio\/olazax-disperzi","title":{"rendered":"Olazax Disperzi"},"content":{"rendered":"<p>Doro\u015bli:<br \/>\nOlanzapina jest wskazana w leczeniu schizofrenii.<br \/>\nOlanzapina jest skuteczna w d\u0142ugoterminowym leczeniu podtrzymuj\u0105cym pacjent\u00f3w, u kt\u00f3rych<br \/>\nstwierdzono dobr\u0105 odpowied\u017a na leczenie w pocz\u0105tkowej fazie terapii.<br \/>\nOlanzapina jest wskazana w leczeniu \u015brednio nasilonych i ci\u0119\u017ckich epizod\u00f3w manii.<br \/>\nU pacjent\u00f3w, u kt\u00f3rych w terapii epizodu manii uzyskano dobr\u0105 odpowied\u017a na leczenie olanzapin\u0105,<br \/>\nolanzapina jest wskazana w celu zapobiegania nawrotom choroby afektywnej dwubiegunowej.<\/p>\n","protected":false},"featured_media":26375,"parent":0,"template":"","active-substance":[367],"product-category":[336],"therapeutic-area":[365],"class_list":["post-26789","portfolio-products","type-portfolio-products","status-publish","has-post-thumbnail","hentry","active-substance-olanzapina","product-category-standardowe-leki-generyczne","therapeutic-area-schizofrenia-i-choroba-afektywna-dwubiegunowa"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Olazax Disperzi - Neuraxpharm PL<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/pl\/portfolio\/olazax-disperzi\" \/>\n<meta property=\"og:locale\" content=\"pl_PL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Olazax Disperzi\" \/>\n<meta property=\"og:description\" content=\"Doro\u015bli: Olanzapina jest wskazana w leczeniu schizofrenii. Olanzapina jest skuteczna w d\u0142ugoterminowym leczeniu podtrzymuj\u0105cym pacjent\u00f3w, u kt\u00f3rych stwierdzono dobr\u0105 odpowied\u017a na leczenie w pocz\u0105tkowej fazie terapii. Olanzapina jest wskazana w leczeniu \u015brednio nasilonych i ci\u0119\u017ckich epizod\u00f3w manii. U pacjent\u00f3w, u kt\u00f3rych w terapii epizodu manii uzyskano dobr\u0105 odpowied\u017a na leczenie olanzapin\u0105, olanzapina jest wskazana w [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/pl\/portfolio\/olazax-disperzi\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm PL\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-07T19:51:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/18\/2021\/06\/olazax-all.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"1000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/pl\/portfolio\/olazax-disperzi\",\"url\":\"https:\/\/www.neuraxpharm.com\/pl\/portfolio\/olazax-disperzi\",\"name\":\"Olazax Disperzi - Neuraxpharm PL\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/pl\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/pl\/portfolio\/olazax-disperzi#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/pl\/portfolio\/olazax-disperzi#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/18\/2021\/06\/olazax-all.png\",\"datePublished\":\"2021-06-29T12:12:20+00:00\",\"dateModified\":\"2023-03-07T19:51:10+00:00\",\"inLanguage\":\"pl-PL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/pl\/portfolio\/olazax-disperzi\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pl-PL\",\"@id\":\"https:\/\/www.neuraxpharm.com\/pl\/portfolio\/olazax-disperzi#primaryimage\",\"url\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/18\/2021\/06\/olazax-all.png\",\"contentUrl\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/18\/2021\/06\/olazax-all.png\",\"width\":1000,\"height\":1000},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/pl\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/pl\/\",\"name\":\"Neuraxpharm PL\",\"description\":\"Ein europ\u00e4ischer Marktf\u00fchrer f\u00fcr CNS-Produkte\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/pl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pl-PL\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Olazax Disperzi - Neuraxpharm PL","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/pl\/portfolio\/olazax-disperzi","og_locale":"pl_PL","og_type":"article","og_title":"Olazax Disperzi","og_description":"Doro\u015bli: Olanzapina jest wskazana w leczeniu schizofrenii. Olanzapina jest skuteczna w d\u0142ugoterminowym leczeniu podtrzymuj\u0105cym pacjent\u00f3w, u kt\u00f3rych stwierdzono dobr\u0105 odpowied\u017a na leczenie w pocz\u0105tkowej fazie terapii. Olanzapina jest wskazana w leczeniu \u015brednio nasilonych i ci\u0119\u017ckich epizod\u00f3w manii. U pacjent\u00f3w, u kt\u00f3rych w terapii epizodu manii uzyskano dobr\u0105 odpowied\u017a na leczenie olanzapin\u0105, olanzapina jest wskazana w [&hellip;]","og_url":"https:\/\/www.neuraxpharm.com\/pl\/portfolio\/olazax-disperzi","og_site_name":"Neuraxpharm PL","article_modified_time":"2023-03-07T19:51:10+00:00","og_image":[{"width":1000,"height":1000,"url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/18\/2021\/06\/olazax-all.png","type":"image\/png"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/pl\/portfolio\/olazax-disperzi","url":"https:\/\/www.neuraxpharm.com\/pl\/portfolio\/olazax-disperzi","name":"Olazax Disperzi - Neuraxpharm PL","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/pl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.neuraxpharm.com\/pl\/portfolio\/olazax-disperzi#primaryimage"},"image":{"@id":"https:\/\/www.neuraxpharm.com\/pl\/portfolio\/olazax-disperzi#primaryimage"},"thumbnailUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/18\/2021\/06\/olazax-all.png","datePublished":"2021-06-29T12:12:20+00:00","dateModified":"2023-03-07T19:51:10+00:00","inLanguage":"pl-PL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/pl\/portfolio\/olazax-disperzi"]}]},{"@type":"ImageObject","inLanguage":"pl-PL","@id":"https:\/\/www.neuraxpharm.com\/pl\/portfolio\/olazax-disperzi#primaryimage","url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/18\/2021\/06\/olazax-all.png","contentUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/18\/2021\/06\/olazax-all.png","width":1000,"height":1000},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/pl\/#website","url":"https:\/\/www.neuraxpharm.com\/pl\/","name":"Neuraxpharm PL","description":"Ein europ\u00e4ischer Marktf\u00fchrer f\u00fcr CNS-Produkte","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/pl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pl-PL"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/pl\/wp-json\/wp\/v2\/portfolio-products\/26789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/pl\/wp-json\/wp\/v2\/portfolio-products"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/pl\/wp-json\/wp\/v2\/types\/portfolio-products"}],"version-history":[{"count":4,"href":"https:\/\/www.neuraxpharm.com\/pl\/wp-json\/wp\/v2\/portfolio-products\/26789\/revisions"}],"predecessor-version":[{"id":28674,"href":"https:\/\/www.neuraxpharm.com\/pl\/wp-json\/wp\/v2\/portfolio-products\/26789\/revisions\/28674"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/pl\/wp-json\/wp\/v2\/media\/26375"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/pl\/wp-json\/wp\/v2\/media?parent=26789"}],"wp:term":[{"taxonomy":"active-substance","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/pl\/wp-json\/wp\/v2\/active-substance?post=26789"},{"taxonomy":"product-category","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/pl\/wp-json\/wp\/v2\/product-category?post=26789"},{"taxonomy":"therapeutic-area","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/pl\/wp-json\/wp\/v2\/therapeutic-area?post=26789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}